Mandate

VINGE ADVISES ELOS AB (PUBL) IN CONJUNCTION WITH THE SALE OF FIXTURLASER AB

June 27, 2014

Vinge has advised Elos AB (publ), listed on NASDAQ OMX, Stockholm, in connection with the sale of the shares in Fixturlaser AB to Acoem, a company within the Evolem group. Fixturlaser develops, manufactures and sells geometry and shaft alignment systems for industrial enterprises. The purchase price for the shares amounts to approximately SEK 142 million on a cash and debt free basis.

Vinge’s team primarily consisted of responsible partner Anders Strid, associates Johanna Björnum Nyström (project manager), Emma Kero Ljungberg (VDD manager), Anna Seisling (employment) Anna Hofling Johansson (tax) and Daniel Lennartsson (M&A).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026